Portfolio company
CoSyne Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops artificial intelligence platforms to discover precision medicines for patients with brain cancer and neurological conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Exin Therapeutics
This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.
Serinus Biosciences
This company develops an artificial intelligence platform to design cancer therapeutics and combination therapies for the pharmaceutical and precision medicine industries.
Sensorium Therapeutics
This biotech company develops central nervous system therapies for patients with anxiety, epilepsy and neurodegenerative diseases using a machine learning drug discovery platform.
Verge
This company provides a technology platform using artificial intelligence and human genomics to discover and develop drugs for patients with neurodegenerative diseases.
Alto Neuroscience
This biopharmaceutical company develops precision medicines for patients with neuropsychiatric conditions by using an artificial intelligence platform to analyse brain-based biomarkers.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
